In the last trading session, 2.12 million Shuttle Pharmaceuticals Holdings Inc (NASDAQ:SHPH) shares changed hands as the company’s beta touched 0.41. With the company’s per share price at $0.19 changed hands at $0.01 or 5.23% during last session, the market valuation stood at $2.12M. SHPH’s last price was a discount, traded about -2163.16% off its 52-week high of $4.30. The share price had its 52-week low at $0.16, which suggests the last value was 15.79% up since then. When we look at Shuttle Pharmaceuticals Holdings Inc’s average trading volume, we note the 10-day average is 1.72 million shares, with the 3-month average coming to 4.67 million.
Shuttle Pharmaceuticals Holdings Inc (NASDAQ:SHPH) trade information
Instantly SHPH was in green as seen at the end of in last trading. With action 11.37%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -77.53%, with the 5-day performance at 11.37% in the green. However, in the 30-day time frame, Shuttle Pharmaceuticals Holdings Inc (NASDAQ:SHPH) is -28.52% down. Looking at the short shares, we see there were 0.7 million shares sold at short interest cover period of 0.06 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -55.05%.
SHPH Dividends
Shuttle Pharmaceuticals Holdings Inc is expected to release its next quarterly earnings report in July.
Shuttle Pharmaceuticals Holdings Inc (NASDAQ:SHPH)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 14.18% of Shuttle Pharmaceuticals Holdings Inc shares while 2.30% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 2.68%. There are 2.30% institutions holding the Shuttle Pharmaceuticals Holdings Inc stock share, with TWO SIGMA SECURITIES, LLC the top institutional holder. As of 2024-06-30, the company held 0.2552% of the shares, roughly 42288.0 SHPH shares worth $16907.0.
GEODE CAPITAL MANAGEMENT, LLC holds the second largest percentage of outstanding shares, with 0.186% or 30823.0 shares worth $12297.0 as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund . With 23.57 shares estimated at $4548.0 under it, the former controlled 0.21% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund held about 0.07% of the shares, roughly 7.21 shares worth around $1392.0.
